Thus, previous studies have suggested that insulin resistance resolution could be a factor driving the reduction in systemic inflammation by showing significant reductions in HOMA-IR before considerable reductions in the levels of IL-6, MCP-1, IL-18, TNF-α19,43,44. The gene discussed is CCL2; the disease is Insulin resistance.